Properties | Information | |
---|---|---|
PhytoCAT-ID | PhytoCAT-1181 | |
Phytochemical name or plant extracts | Schisandrin A | |
PMID | 31048190 | |
Literature evidence | In this study, we evaluated the toxic potential of schisandrin A (SchA), a bioactive phytochemical found in Schisandra chinensis in TNBC. | |
IUPAC name | (9R,10S)-3,4,5,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.02,7]hexadeca-1(16),2,4,6,12,14-hexaene | |
Phytochemicals’ class or type of plant extracts | Lignan | |
Source of phytochemicals or plant Extracts | Schisandrae Chinensis | |
Geographical availability | Amur, China North-Central, Inner Mongolia, Japan, Khabarovsk, Korea, Manchuria, Primorye, Sakhalin | |
Plant parts | Fruits | |
Other cancers | Breast cancer | |
Target gene or protein | p65, STAT-3 | |
Gene or Protein evidence | SchA has been found to reverse doxorubicin-resistant human breast cancer cells (MCF-7/Dox cells) by inhibition of P65 and Stat3 phosphorylation | |
Target pathways | Wnt/ER stress signaling pathway | |
IC50 | 41.43 ± 1.45 μM against MDA-MB-231 134.21 ± 6.85 μM against BT-549 | |
Potency | All of these data indicate that SchA could be a potential candidate for the treatment of TNBC. | |
Cell line/ mice model | MDA-MB-231, BT-549, MDA-MB-231 xenograft mouse model | |
Additional information | SchA has been proved to enhance chemosensitivity of colon cancer cells to 5-fluorouracil through up-regulation of miR-195 | |
PubChem ID | 155256 | |
Additional PMIDs | NA | |
Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:60456331-2 | |
Safety | NA |